StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
100
This year
3
Publishing Date
2023 - 07 - 28
2
2023 - 03 - 10
2
2023 - 01 - 19
2
2023 - 01 - 18
1
2023 - 01 - 04
1
2023 - 01 - 03
1
2022 - 12 - 19
1
2022 - 12 - 09
1
2022 - 12 - 06
1
2022 - 12 - 01
1
2022 - 11 - 15
1
2022 - 11 - 07
2
2022 - 11 - 04
1
2022 - 11 - 02
1
2022 - 10 - 20
2
2022 - 10 - 19
1
2022 - 10 - 17
1
2022 - 10 - 14
1
2022 - 09 - 30
1
2022 - 09 - 23
1
2022 - 09 - 16
1
2022 - 09 - 15
1
2022 - 09 - 08
1
2022 - 09 - 05
1
2022 - 08 - 24
1
2022 - 08 - 23
2
2022 - 08 - 01
1
2022 - 07 - 28
1
2022 - 07 - 25
1
2022 - 07 - 21
1
2022 - 06 - 23
1
2022 - 06 - 20
2
2022 - 06 - 10
1
2022 - 06 - 03
1
2022 - 05 - 11
2
2022 - 05 - 10
1
2022 - 05 - 09
1
2022 - 05 - 03
1
2022 - 04 - 29
1
2022 - 04 - 26
1
2022 - 04 - 12
1
2022 - 04 - 08
1
2022 - 04 - 05
1
2022 - 03 - 24
1
2022 - 03 - 18
1
2022 - 03 - 17
1
2022 - 02 - 04
1
2022 - 01 - 24
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 20
1
2021 - 12 - 16
1
2021 - 12 - 14
1
2021 - 12 - 09
1
2021 - 12 - 02
1
2021 - 11 - 24
1
2021 - 11 - 16
1
2021 - 11 - 09
1
2021 - 10 - 26
1
2021 - 10 - 15
1
Sector
Commercial services
1
Communications
1
Electronic technology
2
Finance
4
Finance and insurance
3
Health technology
100
Manufacturing
7
N/a
5
Technology services
1
Tags
Acquired
1
Active
1
Approval
1
Astrazeneca
1
Biosimilar
1
Bleeding
5
Blood
1
Business
1
Cancer
4
Candidate
1
Cardiovascular
1
Care
1
Cell
1
Children
1
Clearance
1
Clinical-trials-phase-iii
2
Collaboration
2
Companies
4
Conference
11
Device
2
Diabetes
6
Disease
4
Disorders
2
Drug
4
Earnings
5
Europe
5
Events
16
Expected
7
Financial
4
Global
29
Growing
3
Growth
14
Insulin
11
Iph5201
2
Liver
3
Market
46
Money
2
N/a
56
Natural
2
Patent
3
Pharma
42
Pharmaceutical
7
Phase 2
3
Platform
2
Rapid
2
Reach
6
Regulatory
2
Report
26
Research
9
Results
6
Roche
2
Sanofi
7
Set
2
Study
2
Therapeutics
6
Therapy
2
Treatment
7
Trial
4
Update
6
Year
2
Entities
Abbott laboratories
219
Abbvie inc.
167
Alnylam pharmaceuticals, inc.
63
Alphabet inc.
32
Amarin corporation plc
31
Amgen inc.
132
Astellas pharma inc
70
Astrazeneca plc
176
Bausch health companies inc.
24
Baxter international inc.
41
Becton, dickinson and company
26
Biogen inc.
48
Biomarin pharmaceutical inc.
19
Biontech se
128
Boston scientific corporation
19
Bristol-myers squibb company
70
Byline bancorp, inc.
26
Csl ltd
22
Denali therapeutics inc.
19
Eli lilly and company
253
Endo international plc
18
Galapagos nv
36
Gilead sciences, inc.
35
Glaxosmithkline plc
272
Icon plc
12
Igm biosciences, inc.
37
Incyte corporation
102
Innate pharma s.a.
81
Innate pharma sa
81
Insulet corporation
15
Johnson & johnson
458
Kymera therapeutics, inc.
22
Medtronic plc
33
Mobiv acquisition corp
65
Moderna, inc.
22
Morgan stanley
14
Morphosys ag
33
Nektar therapeutics
39
Novartis ag
284
Novo nordisk a/s
100
Nurix therapeutics, inc.
14
Oncocyte corporation
32
Orange
49
Pegasus digital mobility acquisition corp.
17
Perrigo company
103
Pfizer, inc.
90
Provention bio, inc.
283
Ptc therapeutics, inc.
30
Rallybio corp
31
Rcf acquisition corp.
83
Reckitt benckiser group plc
20
Regeneron pharmaceuticals, inc.
188
Sanofi
3597
Takeda pharmaceutical company limited
51
Teva pharmaceutical industries limited
17
Teva pharmaceutical industries ltd
224
Therapeuticsmd, inc.
30
Thermo fisher scientific inc
36
Vaxart, inc.
31
Viatris inc.
81
Symbols
ABBV
14
ABT
20
ALNY
25
ALPMF
3
ALPMY
3
ALT
2
AMGN
17
AMZN
2
AZN
30
AZNCF
20
BAX
8
BDX
12
BHC
2
BIIB
7
BLK
5
BMY
7
BNPQF
3
BNPQY
3
BSX
3
CMXHF
3
CRL
2
CSLLY
3
CTLT
2
DNLI
2
DXCM
3
EIGR
2
ENDP
5
ENDPQ
4
ENTX
2
GALT
3
GILD
10
GLAXF
21
GMAB
4
GSK
27
ICLR
5
IONS
3
IPHA
71
IPHYF
44
JNJ
44
LLY
83
LPCN
3
MDGL
3
MDT
14
NVO
632
NVS
28
NVSEF
27
PFE
11
PODD
11
REGN
4
RVP
4
SNY
139
SNYNF
100
TAK
15
TEVJF
15
TMO
4
TRUMF
9
TRUMY
9
VRTX
3
VTRS
7
ZEAL
9
Exchanges
Amex
2
Nasdaq
100
Nyse
100
Crawled Date
2023 - 07 - 28
2
2023 - 02 - 23
2
2023 - 01 - 19
2
2023 - 01 - 18
1
2023 - 01 - 04
1
2023 - 01 - 03
1
2022 - 12 - 19
1
2022 - 12 - 09
1
2022 - 12 - 06
1
2022 - 12 - 01
1
2022 - 11 - 15
1
2022 - 11 - 07
2
2022 - 11 - 04
1
2022 - 11 - 02
1
2022 - 10 - 20
2
2022 - 10 - 19
1
2022 - 10 - 17
1
2022 - 10 - 14
1
2022 - 09 - 30
1
2022 - 09 - 23
1
2022 - 09 - 16
1
2022 - 09 - 15
1
2022 - 09 - 08
1
2022 - 09 - 05
1
2022 - 08 - 24
1
2022 - 08 - 23
2
2022 - 08 - 01
1
2022 - 07 - 28
1
2022 - 07 - 25
1
2022 - 07 - 21
1
2022 - 06 - 23
1
2022 - 06 - 20
2
2022 - 06 - 10
1
2022 - 06 - 03
1
2022 - 05 - 11
2
2022 - 05 - 10
1
2022 - 05 - 09
1
2022 - 05 - 03
1
2022 - 04 - 29
1
2022 - 04 - 26
1
2022 - 04 - 12
1
2022 - 04 - 08
1
2022 - 04 - 05
1
2022 - 03 - 24
1
2022 - 03 - 18
1
2022 - 03 - 17
1
2022 - 02 - 04
1
2022 - 01 - 24
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 20
1
2021 - 12 - 16
1
2021 - 12 - 14
1
2021 - 12 - 09
1
2021 - 12 - 02
1
2021 - 11 - 24
1
2021 - 11 - 16
1
2021 - 11 - 09
1
2021 - 10 - 26
1
2021 - 10 - 15
1
Crawled Time
00:00
1
00:20
1
01:00
3
02:00
3
04:20
1
06:00
3
07:00
14
08:00
10
09:00
6
10:00
7
11:00
5
12:00
5
12:30
1
13:00
3
14:00
1
15:00
3
15:20
2
15:30
1
16:00
4
17:00
6
18:00
3
19:00
3
20:00
2
21:00
5
22:00
5
23:00
2
Source
www.biospace.com
44
www.globenewswire.com
1
www.prnewswire.com
55
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Novo nordisk a::S
symbols :
Snynf
save search
Global Antidiabetics Market 10 Year Forecast Report 2024-2034, by Product Type, by Application, by Distribution Channel and Region
Published:
2024-03-13
(Crawled : 18:00)
- prnewswire.com
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-9.18%
|
O:
-0.64%
H:
0.94%
C:
-0.56%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.36%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-3.79%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-10.73%
|
O:
0.41%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.22%
|
O:
-0.04%
H:
0.0%
C:
0.0%
report
distribution
year
global
market
Insulin Pen Global Market Outlook Report 2024-2028: Current Market Size and Revenue Growth Prospects for Insulin Pens, with Market Share Analysis by Type, Onset Time, End User and Geographical Region
Published:
2024-02-23
(Crawled : 17:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.97%
|
O:
0.37%
H:
0.58%
C:
0.58%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-15.79%
|
O:
0.0%
H:
1.93%
C:
1.27%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-1.45%
|
O:
-0.68%
H:
0.4%
C:
-0.18%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.21%
|
O:
0.89%
H:
0.4%
C:
0.17%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.82%
|
O:
0.28%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.37%
|
O:
0.97%
H:
0.0%
C:
0.0%
report
revenue
global
insulin
growth
market
Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics
Published:
2024-01-10
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-10.95%
|
O:
1.1%
H:
0.0%
C:
0.0%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
12.92%
|
O:
-0.33%
H:
0.35%
C:
-1.5%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
15.25%
|
O:
0.67%
H:
0.85%
C:
0.21%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-10.93%
|
O:
0.69%
H:
0.0%
C:
0.0%
ALDX
|
$3.865
-2.89%
-2.98%
430K
|
Health Technology
|
15.57%
|
O:
-1.8%
H:
0.46%
C:
-2.44%
companies
therapeutics
growth
market
Biologics Global Market Forecast Report 2024-2034 - Challenges Posed by Patent Expiration for Biologics
Published:
2023-12-22
(Crawled : 17:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.25%
|
O:
3.66%
H:
0.0%
C:
-0.12%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
4.37%
|
O:
3.33%
H:
0.0%
C:
-2.93%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
18.58%
|
O:
-0.31%
H:
0.39%
C:
-0.44%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-3.65%
|
O:
1.09%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
26.98%
|
O:
0.18%
H:
0.5%
C:
-0.46%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-4.55%
|
O:
-0.78%
H:
5.15%
C:
2.81%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
9.06%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.99%
|
O:
1.03%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
6.53%
|
O:
0.52%
H:
0.58%
C:
0.05%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-15.42%
|
O:
0.34%
H:
1.02%
C:
0.59%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-23.43%
|
O:
0.57%
H:
1.36%
C:
1.04%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.39%
|
O:
1.06%
H:
0.18%
C:
-1.06%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-3.72%
|
O:
0.24%
H:
2.03%
C:
1.49%
patent
report
global
market
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published:
2023-12-19
(Crawled : 08:00)
- biospace.com/
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
23.97%
|
O:
0.91%
H:
0.72%
C:
0.11%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.44%
|
O:
0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-0.41%
|
O:
13.88%
H:
0.0%
C:
-3.58%
pharma
natural
cell
sanofi
Incretin-based Drugs Market to Reach $73.9 billion, globally, by 2032 at 7.9% CAGR: Allied Market Research
Published:
2023-12-15
(Crawled : 15:30)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
2.8%
|
O:
-3.0%
H:
2.15%
C:
2.15%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.45%
|
O:
0.0%
H:
0.0%
C:
0.0%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
25.21%
|
O:
-0.48%
H:
0.0%
C:
-0.44%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-4.56%
|
O:
-1.31%
H:
0.56%
C:
-0.17%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
22.34%
|
O:
-4.44%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.14%
|
O:
-0.93%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.32%
|
O:
-2.23%
H:
0.28%
C:
-0.11%
reach
research
market
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published:
2023-12-08
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-21.02%
|
O:
-2.79%
H:
0.62%
C:
0.62%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
2.34%
|
O:
2.06%
H:
0.82%
C:
0.82%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-3.34%
|
O:
-1.29%
H:
0.4%
C:
0.4%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-22.51%
|
O:
-2.2%
H:
0.0%
C:
-0.27%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-5.97%
|
O:
-0.64%
H:
0.5%
C:
0.5%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
26.75%
|
O:
-0.42%
H:
0.67%
C:
0.25%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.64%
|
O:
0.19%
H:
0.35%
C:
0.2%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-5.17%
|
O:
-0.18%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
23.82%
|
O:
0.43%
H:
0.0%
C:
0.0%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-2.45%
|
O:
0.2%
H:
0.55%
C:
0.1%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
12.6%
|
O:
0.3%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
1.27%
|
O:
1.07%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-14.47%
|
O:
0.08%
H:
1.45%
C:
1.17%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-0.88%
|
O:
-0.05%
H:
0.3%
C:
-0.76%
reach
market
Type 1 Diabetes Market to Accelerate Substantially During the Study Period (2019-2032), Predicts DelveInsight | Leading Companies Developing Therapies - Eli Lilly, Vertex, Bayer, Novo Nordisk, Rise, Tolerion, BioKier, Dompé Farmaceutici
Published:
2023-11-15
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
4.94%
|
O:
3.37%
H:
1.29%
C:
1.29%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
27.25%
|
O:
2.62%
H:
0.67%
C:
0.58%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
18.97%
|
O:
-3.12%
H:
0.61%
C:
-0.46%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
12.86%
|
O:
0.4%
H:
0.38%
C:
-2.2%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
2.07%
|
O:
1.54%
H:
0.0%
C:
0.0%
companies
diabetes
study
market
Global Glucagon-like Peptide 1 (GLP-1) Market Report 2023: Key Players Include Pfizer Inc., AstraZeneca PLC, Sanofi, Novo Nordisk Among Others
Published:
2023-11-11
(Crawled : 04:20)
- prnewswire.com
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
report
astrazeneca
global
market
Addressing the Global HIV Challenge: Market for Diagnostics and Therapeutics Plays a Crucial Role in Combating HIV/AIDS
Published:
2023-11-03
(Crawled : 17:00)
- prnewswire.com
TRUMF
|
$16.928
-17.59%
1.9K
|
Health Technology
|
-39.61%
|
O:
-0.28%
H:
4.55%
C:
0.01%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.22%
|
O:
-1.79%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
0.42%
|
O:
-1.88%
H:
3.51%
C:
2.73%
TRUMY
|
$16.507
0.79%
34K
|
Manufacturing
|
-41.84%
|
O:
3.89%
H:
0.0%
C:
-1.74%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
22.59%
|
O:
2.32%
H:
0.0%
C:
0.0%
QGEN
|
$40.0
1.34%
0.0%
1.1M
|
Health Technology
|
4.63%
|
O:
2.12%
H:
1.06%
C:
0.51%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
21.58%
|
O:
-2.23%
H:
0.16%
C:
-0.52%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.3%
|
O:
-1.4%
H:
0.42%
C:
0.0%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
0.18%
|
O:
2.15%
H:
0.0%
C:
0.0%
BDX
|
$234.12
0.42%
0.0%
1.3M
|
Health Technology
|
-8.52%
|
O:
1.1%
H:
0.33%
C:
0.07%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.51%
|
O:
-3.04%
H:
0.0%
C:
0.0%
QGEN
|
$40.0
1.34%
0.0%
1.1M
|
Health Technology
|
4.63%
|
O:
2.12%
H:
1.06%
C:
0.51%
global
hiv
diagnostics
therapeutics
market
Medical Segment Dominates, Expected to Reach $70.4 Billion by 2030 in the Global Recombinant DNA Technology Market
Published:
2023-11-01
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
12.22%
|
O:
-1.62%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
3.73%
|
O:
0.94%
H:
2.55%
C:
2.55%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
2.99%
|
O:
2.52%
H:
0.04%
C:
0.04%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
27.07%
|
O:
0.87%
H:
0.73%
C:
0.28%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.83%
|
O:
0.16%
H:
0.7%
C:
0.57%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
11.34%
|
O:
-4.06%
H:
1.9%
C:
0.96%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
27.81%
|
O:
-2.76%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
1.62%
|
O:
0.18%
H:
0.0%
C:
0.0%
expected
reach
global
dna
medical
technology
market
Global Bleeding Disorders Treatment Market Surpasses $14 Billion in 2022, Expected to Reach $20.3 Billion by 2028
Published:
2023-10-25
(Crawled : 22:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-8.69%
|
O:
-4.69%
H:
0.69%
C:
-3.18%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
25.95%
|
O:
-1.47%
H:
0.22%
C:
-0.83%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-2.41%
|
O:
0.1%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-12.79%
|
O:
0.09%
H:
0.0%
C:
0.0%
bleeding
expected
reach
disorders
treatment
global
market
Global Generic Drugs Business Analysis Report 2023-2030: Small-molecule Generic Drugs Account for a Lion's Share, Biosimilars Exhibit Fastest Growth
Published:
2023-10-23
(Crawled : 19:00)
- prnewswire.com
ENDPQ
|
$0.0006
-50.0%
3.4K
|
n/a
|
-55.56%
|
O:
-44.44%
H:
60.0%
C:
-20.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
10.06%
|
O:
1.37%
H:
1.36%
C:
1.36%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
26.12%
|
O:
0.45%
H:
2.46%
C:
1.67%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
26.35%
|
O:
-0.79%
H:
1.41%
C:
1.21%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
23.98%
|
O:
-0.84%
H:
0.0%
C:
0.0%
BAX
|
$39.47
-0.45%
0.0%
2.8M
|
Health Technology
|
20.15%
|
O:
0.2%
H:
0.9%
C:
-1.05%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
10.4%
|
O:
-1.82%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-10.94%
|
O:
0.77%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
8.72%
|
O:
0.38%
H:
2.31%
C:
2.02%
report
business
global
growth
The Evolving Market Dynamics of Factor-based Bleeding Disorders: Hemophilia A, Hemophilia B, and Von Willebrand Disease | Key Analysis by DelveInsight
Published:
2023-10-09
(Crawled : 21:00)
- prnewswire.com
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
33.29%
|
O:
0.09%
H:
1.41%
C:
0.94%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-5.99%
|
O:
0.67%
H:
0.56%
C:
-0.01%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-14.21%
|
O:
0.51%
H:
0.0%
C:
0.0%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-7.64%
|
O:
0.48%
H:
1.39%
C:
0.51%
ALPN
|
$64.535
0.16%
0.16%
4M
|
Health Technology
|
449.98%
|
O:
-1.07%
H:
0.0%
C:
-6.9%
bleeding
disease
market
Global Bleeding Disorders Market Set to Surge, Expected to Reach $25.97 Billion by 2032 with a 6.6% CAGR
Published:
2023-09-27
(Crawled : 02:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-14.76%
|
O:
-0.69%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-17.04%
|
O:
0.56%
H:
0.06%
C:
-0.62%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
33.69%
|
O:
-0.51%
H:
0.62%
C:
0.42%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-14.61%
|
O:
-0.5%
H:
0.0%
C:
0.0%
GRFS
|
News
|
$6.29
-3.82%
-3.97%
1.2M
|
Health Technology
|
-31.44%
|
O:
-0.22%
H:
1.09%
C:
-0.55%
bleeding
expected
reach
disorders
global
set
market
Atherosclerotic Cardiovascular Disease Market to Observe Impressive Growth at a CAGR of 2.2% by 2032, Predicts DelveInsight
Published:
2023-09-26
(Crawled : 21:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-14.76%
|
O:
-0.69%
H:
0.0%
C:
0.0%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
33.69%
|
O:
-0.51%
H:
0.62%
C:
0.42%
BSX
|
$67.33
-0.13%
-0.31%
7M
|
Health Technology
|
27.45%
|
O:
-0.09%
H:
0.72%
C:
-1.29%
SLN
|
$22.75
3.32%
3.21%
310K
|
Health Technology
|
127.08%
|
O:
-1.3%
H:
2.44%
C:
-1.42%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-14.61%
|
O:
-0.5%
H:
0.0%
C:
0.0%
MESO
|
$5.19
1.57%
1.54%
230K
|
Health Technology
|
-47.05%
|
O:
3.25%
H:
1.57%
C:
-3.15%
IONS
|
$40.64
-0.42%
-0.42%
850K
|
Health Technology
|
-12.1%
|
O:
0.99%
H:
2.09%
C:
0.83%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-0.04%
|
O:
1.0%
H:
0.69%
C:
-1.01%
disease
cardiovascular
growth
market
Global Hemophilia Research Analysis Report 2023: A $21.07 Billion Market by 2030 - Approval of Gene Therapies and Monoclonal Antibodies Fueling Growth
Published:
2023-08-16
(Crawled : 01:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-12.84%
|
O:
-0.26%
H:
0.26%
C:
-0.46%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-26.53%
|
O:
-0.71%
H:
1.45%
C:
0.97%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
32.58%
|
O:
-0.3%
H:
1.35%
C:
0.05%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.0%
|
O:
-1.33%
H:
0.0%
C:
0.0%
report
approval
research
global
growth
market
Global Insulin Pen Market Projected to Reach $73.39 Billion by 2028 with Steady CAGR of 5.25% during 2023-2028
Published:
2023-07-28
(Crawled : 19:00)
- prnewswire.com
TRUMY
|
$16.507
0.79%
34K
|
Manufacturing
|
Email alert
Add to watchlist
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
TRUMF
|
$16.928
-17.59%
1.9K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
reach
global
insulin
market
The Worldwide Generic Drugs Market is Expected to Grow at a CAGR of over 6.51% During 2018-2028
Published:
2023-07-28
(Crawled : 02:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
7.83%
|
O:
-2.63%
H:
2.59%
C:
1.75%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
8.91%
|
O:
1.16%
H:
0.0%
C:
-0.48%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-21.67%
|
O:
-0.01%
H:
0.93%
C:
0.75%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.12%
|
O:
0.36%
H:
0.09%
C:
-0.02%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-6.25%
|
O:
-1.09%
H:
0.3%
C:
-0.4%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.54%
|
O:
-3.09%
H:
0.0%
C:
0.0%
expected
market
Chronic Kidney Disease - Market Insight, Epidemiology and Market Forecast 2023-2032: With Focus on United States, EU4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan
Published:
2023-06-28
(Crawled : 02:00)
- prnewswire.com
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-21.33%
|
O:
1.47%
H:
0.0%
C:
-0.94%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
56.36%
|
O:
0.86%
H:
0.0%
C:
-2.09%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.57%
|
O:
0.75%
H:
0.0%
C:
0.0%
RETA
|
$172.36
0.02%
0.03%
0
|
Health Technology
|
86.56%
|
O:
6.1%
H:
5.34%
C:
0.82%
disease
japan
kidney
market
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.